Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
Breast Cancer Research : BCR
|
February 1, 2003
BAD: a good therapeutic target?
Andrea B Motoyama, Nancy E Hynes
Breast Cancer Research : BCR
|
November 1, 2013
AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer--culprits for resistance to EGFR inhibitors?
Marinus R Heideman, Nancy E Hynes
Experimental Cell Research
|
March 22, 2003
The ErbB receptors and their role in cancer progression
Thomas Holbro, Gianluca Civenni, Nancy E Hynes
Oncogene
|
April 30, 2004
Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins
Magdalena Koziczak, Thomas Holbro, Nancy E Hynes
EMBO Reports
|
March 4, 2003
Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells
Gianluca Civenni, Thomas Holbro, Nancy E Hynes
Cancer Discovery
|
September 4, 2015
Targeting a Novel ER/HOXB7 Signaling Loop in Tamoxifen-Resistant Breast Cancer
Marinus R Heideman, Anna Frei, Nancy E Hynes
Oncogene
|
June 27, 2002
Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells
Richard M Neve, Thomas Holbro, Nancy E Hynes
BMC Biology
|
September 30, 2009
c-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland
Tina Stoelzle, Patrick Schwarb, Andreas Trumpp, et al.
Cancer Research
|
May 31, 2002
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides
Andrea B Motoyama, Nancy E Hynes, Heidi A Lane
The Journal of Biological Chemistry
|
July 2, 2004
TEL/ETV6 is a signal transducer and activator of transcription 3 (Stat3)-induced repressor of Stat3 activity
Nicole Schick, Edward J Oakeley, Nancy E Hynes, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
Breast Cancer Research : BCR
|
February 1, 2003
BAD: a good therapeutic target?
Andrea B Motoyama, Nancy E Hynes
Breast Cancer Research : BCR
|
November 1, 2013
AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer--culprits for resistance to EGFR inhibitors?
Marinus R Heideman, Nancy E Hynes
Experimental Cell Research
|
March 22, 2003
The ErbB receptors and their role in cancer progression
Thomas Holbro, Gianluca Civenni, Nancy E Hynes
Oncogene
|
April 30, 2004
Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins
Magdalena Koziczak, Thomas Holbro, Nancy E Hynes
EMBO Reports
|
March 4, 2003
Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells
Gianluca Civenni, Thomas Holbro, Nancy E Hynes
Cancer Discovery
|
September 4, 2015
Targeting a Novel ER/HOXB7 Signaling Loop in Tamoxifen-Resistant Breast Cancer
Marinus R Heideman, Anna Frei, Nancy E Hynes
Oncogene
|
June 27, 2002
Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells
Richard M Neve, Thomas Holbro, Nancy E Hynes
BMC Biology
|
September 30, 2009
c-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland
Tina Stoelzle, Patrick Schwarb, Andreas Trumpp, et al.
Cancer Research
|
May 31, 2002
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides
Andrea B Motoyama, Nancy E Hynes, Heidi A Lane
The Journal of Biological Chemistry
|
July 2, 2004
TEL/ETV6 is a signal transducer and activator of transcription 3 (Stat3)-induced repressor of Stat3 activity
Nicole Schick, Edward J Oakeley, Nancy E Hynes, et al.
Page
of 9